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I. Summary 
The role of tumor necrosis factor alpha (TNFo0 
in endotoxin-induced shock was investigated in pigs 
receiving 5/~g kg -~ of Escherichia coli endotoxin 
(LPS)during 60 rain of continuous infusion intothe 
superior mesenteric artery. I_PS concentration i
aortic plasma, as determined by a chromogenic 
Limtdus amoebocyte lysate (LAL) test, reached a 
peak of approximately 1000 ng I -t during LPS infu- 
sion, and declined rapidly after discontinuation of 
the infusion. Serum TNF levels were determined by 
a bioassay using the L929 murine transformed 
fibroblast line. Eight of the 17 animals infused with 
LPS died within 30 min after beginning LPS ad- 
ministration, while the other 9 pigs survived beyond 
the experimental observation period of 3 h, 
although they were in a state of shock. No difference 
in LPS concentration was found between the sur- 
ivors and the non-survivors. However, the serum 
TNF levels in non-survivors were significantly 
higher than in sur~,ivors when measured at 30 min 
after beginning LPS administration. In survivors, 
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the peak increase in serum TNF levels was measured 
at 60 rain after the beginning of LPS injection and 
returned rapidly to the baseline values. Although the 
role of TNF inducing rapid death seems to be domi- 
nant, the hemodynamic, hematology and blood 
chemistry disturbances seen during shock continued 
in survivors long after the return of TNF to baseline 
levels. These findings indicate that besides TNF oth- 
er mediators are also invol~ed in the LPS infusion- 
induced shock. 
2. Introduction 
The involvement of TNFa. as a crucial mediator 
in shock, inflammation and cachexia has been pro- 
posed [I] on the basis of three different lines of evi- 
dence. First, increase in TNF levels was reported in 
animal models of shock and other forms of acute in- 
flammation [2, 3]. The increase in TNF levels was 
correlated to the intensity of septic shock and was 
also found to occur in patients dying from menin- 
gococcal septicemia [4]. Second, antibodies against 
TNF protected septic shock in routine, rabbit and 
baboon models [5-7]. Third, administration of TNF 
itself can induce hemod.vnamic and laboratory 
changes, which are characteristics for septic shock 
[8, 91. 
Some findings indicate, however, that differences 
exist between shock induced by LPS and shock in- 
duced by TNF itself. The kinetics of hemodynamic, 
hematologic and blood chemistry changes differ be- 
tween the two kinds of shock [I0]. Moreover, the 
plasma levels of TNF required to induce death are 
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much higher than the serum TNF levels induced b.~ 
a lethal dose of LPS [3]. The treatment ~ith anti- 
body against TNF is not successful if given I h be- 
fore administration of bacterial infusion [6]. These 
data indicate that besides TNF some other inflam- 
matory mediators may play a role in the pathogene- 
sis of endotoxic shock. 
During our study on shock induced in pigs by in- 
fusion of LPS, ~e found an almost even distribution 
in the pig population of susceptibility to the lethal 
effects of LPS. Thus, this model provided an oppor- 
tunity to determine the relationship between suscep- 
tibility to the lethal effects of LPS infusion and TNF 
levels, and the hemodynamic, hematologic and 
blood chemistry changes induced by LPS. The aim 
of the present ~ork was to investigate the existence 
of such a relationship. 
3. Materials and Melhods 
3. I. Experimental set-up 
E. coli LPS (5 ~g kg -~ of O111 B4, Serva) x~as in- 
fused into the superior mesenteric artery o~er 
60 min in pigs (female, age 13-15 ~eeks) anesthe- 
tized with pentobarbital sodium (20 mg kg -~, i.v.) 
after pre-medication ~ith ketamine (20 mg kg -~, 
i.m.). The animals were subsequently observed for a 
further period of 120 rain. The surgical preparation 
was performed as described in detail elsewhere [I I]. 
The core temperature was measured with a ther- 
mometer (Phi[ips, HP 5311, Japan) attached to the 
li~er. Mean arterial blood pressure (MABP) ~.as con- 
tinuously monitored by electromanometer using 
Statham P 23 dB strain gauge (Hato Rey, PR). 
Cardiac output (CO) was determined intermittently 
by thermodilution (WTI Computer, The 
Netherlands). 
3.2. Experimental protocols 
Group I (sham operated). Three animals were pre- 
pared as described above, except hat instead of LPS, 
physiological saline was infused into the superior 
mesenteric artery. Blood (5 ml) was collected from 
pulmonary artery for laboratory measurements. 
Group 11 (LPS-induced shock). Seventeen pigs were 
infused with 5 /ag kg -~ of E. coli LPS into the su- 
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perior mesenteric artery over a 60-min period and 
the animals were obsersed for an additional 120-min 
period. Blood (5 ml) was collected each time from 
aorta for LPS and TNF measurements at 10 rain be- 
fore, 10, 30 and 60 min after the start of LPS infu- 
sion, 60 and 120 rain after termination of LPS in- 
fusion. 
3.3. Assay for plasma levels of LPS 
Blood for LPS assay ~as collected in plastic tubes 
(Falcon 2063, Oxnard, CA, U.S.A.) pre-filled with 
p.vrogen-free heparin (Thromboliquine '~', Organon, 
Oss, The Netherlands) at a final concentration of 
30 U I -~ . After mixing, these tubes were immediate- 
ly immersed in melting ice. Plasma was obtained b3 
centrifugation at 160 × g at 4'~C for 10 rain and plas- 
ma aliquots were stored at -70°C. LPS ~as assayed 
with a chromogenic Limulus test [12]. All assays 
were performed in duplicate. 
3.4. Assay lor serum levels of TNF 
Blood was collected in sterile tubes (Costar, Cam- 
bridge, MA). Serum ~as separated rapidly after 
coagulation by centrifugation and aliquots ~ere 
stored at -20¢C until assay. TNF activity was deter- 
mined by measuring the cytostatic effect of TNFa 
on the murine transformed fibrob[ast cell line k929 
(a gift from W. Fiers, State University of Ghent, Bel- 
gium) [13, 14]. I_929 cells were plated in a 96-x~ell 
flat-bottomed microtiter plate (NUNC, Roskilde, 
Denmark) at a density of l x 10 a cells per well in 
25 p,I of RPMI-1640 cuhure medium. To quadrupli- 
cate wells, 25 ~1 medium (control), human recom- 
binant TNF standard solutions (10, 100, 1000 U 
m[ -~) (Roche Research, Ghent, Belgium) or serum 
were added (final dilution I:10). After incubation for 
24 h in humidified atmosphere (7.5% CO,) at 
37 "-C, 50/al of a 10-/aCi ml -~ [3H]thymidine (Amer- 
sham Laboratories, Amersham, U.K.) solution wa,~ 
added. After 2 h of incubation I_929 cells ~ere har- 
vested on glass fiber filtermats (Shatron Inc., Ster- 
ring, VA, U.S.A.). The uptake of [3H]thymidine was 
measured by liquid scintillation spectroscop~. A 
standard curve of cytostasis by human recombinant 
TNF ~as obtained yielding progressive cytostasis 
ranging from 10-1000 U m[ -I of TNE The bioac- 
ti~ity of TNF in experimental samples was deter- 
mined in quadrup l i ca te  and compared  against  the 
s tandard  curve. 
3.5. Determination of blood chemistry values 
P lasma g lucose concent ra t ions  were measured  by 
G lucoquant  kit (Boehr inger ,  Mannhe im,  F.R.G.). 
Laboratory  values o f  b lood  hemoglob in ,  hematocr i t  
as x~ell as leukocyte and platelet counts  were meas-  
ured by hemato logy  analyzers  (Sysmex CC-108 and 
PI-100, Kobe, Japan ,  as appropr ia te ) .  
3.6. Statistical analysis 
All values are expressed as means  ~ SEM.  The 
data  were evaluated by the two-way analysis  o f  vari- 
ance (F r iedman test) fo l lowed by a W.' i lcoxon-Wilcox 
test or  two-ta i led Mann-Whi tney  U test, as ap-  
propr iate.  A p value o f  0.05 or  less was cons idered  
stat ist ical ly s igni f icant  for all tests. 
TABLE I 
4. Resu l l s  
4. I. Sham-operated animals 
In sham-operated  an imals  systemic hemodynam-  
ic ~ariables and laboratory  ~,alues ~ere stable dur ing  
the exper iment  (Table I, Group  I). 
4.2. LPS-treated animals 
Eight o f  the 17 an imals  treated with LPS  died 
~ i th in  30 min after  LPS  infus ion was started (non-  
survi~,ors), whi le the other  9 surx i~ed the experinaen- 
tal per iod o f  3 h (2 h af ter  te rminat ion  o f  LPS  infu- 
sion), though in a state o f  shock (sur~ ivors). 
Systemic hemodynamics (Table 1, Group IlL I n sur- 
vivors, mean arterial  b lood  pressure (MABP)  gradu-  
ally decreased and was s igni f icant ly  Io~.er than the 
basel ine f rom the end o f  LPS  infus ion per iod on-  
wards. In contrast ,  MABP in the non-surv ivors  dra- 
mat ica l ly  d ropped f rom 15-30 min after the start o f  
LPS infus ion.  At 25-30 min MABP in this g roup  
Effects of E. colt LPS infusion on hemodynami~, and blood parameters in anesthetized pigs. 
MABP CO Temperature Hb WBC Platelet Blood 
(mmHg) (I rain ~) (~C) (mM I-t) (G I i) count glucose 
(ram I [) 
Group l: sham operated (n = 3P 
Control 99 _+ 8 2.7 _+ 0.4 38.6 + 0.3 5. 7 -* 0.4 13.5 -+ 2.3 350 _+ 49 6.0 ___ 0.24 
60 rain 116-.8 2.8±0.1 39.1 _*0.5 6.0_+0.4 20.0___5.0 340 ~- 48 6.3_+0.26 
120 rain 114+_2 2.2_.0.1 39.2_*0.4 6.1 +_0.5 21).1)+_5.0 330_*49 5.8_+0.17 
180 rain 121 _+ 8 2.4 +_0.3 39.5 _*0.4 6.3 _*0 .4  20.0+_6.0 330_* 52 5.8 +_0.36 
Group II: LPS infusion-induced shock (n = 17) 
Sur~i~or~ (n =9) 
Control 108 _+ 3 2.8 ___ 0.3 39.3 ± 0.3 6.6 _+ 0.2 11.5 -+ 1.5 340 -+ 41 5.3 +_ 0.30 
15 rain 106_+ 5 2.1 _*0 .3  38.6_*0.2 7.0_+0.2 9.7 _* 1.2 330_+46 5.5 _*0.30 
30 rain 89+_7 1.5_.0.1" 38.8_*0.3 ".5_+0.2' 5.4_+ 1.1' 260-+3 "" 5.6_*0.32 
60 rain "7,2 +_ 7* 2.0 _* 0.2 39.3 _* 0.2" 7.5 _+ 0.2" 4.5 _*0.8* 230 _ 33" 5.0 _* 0.30 
120 min 66 _* 6* 1.3 ___ O. I * 39.9 _* 0.3* "7..5 +_ 0.2' 4.1 _* 1.2" 230 _* 38" 4.2 _+ 0.20* 
180 rain 55 _.5" 1.0+_0.1' 40.5 _*0.3* 7.7 _+0.3" 5.4-* 1.1' 210-+ 32* 2.8 _+0.40* 
Non-surx i,,or_., In - 8) 
Control 110___5 2.8+_0.1 39.3-+0.3 6.1 _+0.3 11.4_+0.6 370z 34 5.4_+0.15 
15 rain 92 _+ 8 1.9 +_ 0. I 39.5 -+ 0.4 6.5 -+ 0.3 10.2 +- 0.8 320 ± 313 6.0 _+ 0.33 
30 rain 28+_2" 1 .0+_0 .1"  39.9-+0.3" 6.7_0.2" 6.1 _+ 0.7" 260 ± 31 i 9.4_+0.84* 
Values are means -* SEM; n is number of observations. Abbreviations: MABP. mean arterial blood pressure; CO, cardiac output; Hb, 
hemoglobin: ~,~,BC, white blood cells. *, < 0.05 represents the probabdlt.~  alues at de fferent ime periods compared to those at the baseline 
(control) calculated by the 2-~ay anal.~sis of variance (Friedman test) follo~ed b.~ ~,~,)lcoxon-%Vilco\" test. 
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~as 28_+2 mmHg and animals died 30 rain after 
starting LPS infusion. In survivors there was a 
marked transient decrease in cardiac output from 
25-30 rain after starting LPS infusion. Subsequent- 
[y, cardiac output returned to about baseline [exels 
in spite of the continuous LPS infusion. From 
120 min (I h after stopping LPS administration) 
cardiac output again tended to decline, whereas the 
concentration of  LPS in the circulation returned to 
the baseline levels. In non-survkors,  cardiac output 
decreased quickly to one-third of  baseline ~alues 
within 25 rain after the start of  LPS infusion. 
In non-survivors basal core temperature was 
higher by 1 °C than in survivors (Table I, Group [I, 
p<0.05,  n= 17). Temperature ~as elevated in both 
groups follo~ing LPS infusion. 
Laboratory measurements (Table 1, Group ID. LPS 
infusion induced a rapid increase in hemoglobin 
values, e~ ident from 30 min after commencement of  
LPS infusion. This hemoconcentration was appar- 
ent to~ard the end of the observation period and did 
not improve after the LPS infusion was stopped. The 
LPS infusion was follo~ed by a similar decrease in 
WBC and platele[ counts at 30 rain of  LPS infusion 
in both survivors and non-survivors. After the LPS 
infusion ~sas stopped, WBC and platelet counts in 
the st.rvixors remained significantly lower than 
baseline. In non-surs ixors a clear hypergl.vcen3ia de- 
veloped, ~s hile sur~ i~ors shossed severe 
hypoglycemia. 
4.3. LPS determinations (Fig. 1) 
The basal concentration of  LPS was 520_+47 ng 
I ~ (n=6) in aortic plasma prior to the start of  LPS 
infusion. There ~ere no differences in plasma LPS 
Imels bet~een survivors and non-survivors 
(460+40 ng 1 -[ and 580_+78 ng 1 -I, respectb, el.~, 
n = 3 each). A peak in the LPS levels ~as reached at 
30 rain after the start of  LPS infusion and remained 
constant till the end of the infusion period. The 
differences bet~een peak concentrations observed in 
survivors and non-survivors were not statisticalb 
significant O20_+190 ng 1 -I and 1026~203 ng 1-1, 
n = 3 each). The plasma LPS levels rapidly declined 
after the stoppage of  LPS infusion and returned to 
the baseline in 60 min (560_+162 ng I -I, n=3).  
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Fig,. I . .Aor t i c  pla`,ma endotoxm concentratton> (ng I ~) alter en- 
dotoxin (LPS) infusion into the superior me.~enteric artery, in 
anesthetized plg~. Endoto \m infusion '.sas 5 ,ug kg t from 0-60 
min. Values are means z SEM. Closed c~rele,~ mdicale [ho,e 
ammals  that ~ur~ ived the obser,.ation period of 3 h after startmg 
LPS infusion q~urvitor`,, n 3). Open circle~ indicate tho~e 
animals that dmd in 30 rain after  ` ,tarring LPS infuston (non- 
• ,ur~ ivors, n 3~. *, represent,, the probabiht~, ~alue, at different 
ume period,; compared to tho,~e at the baseline calculated b.,, the 
2-~av anal5 _,,it of ~ ariance (Friedman test) fol lo~ed b} ~.l, ilcox,'m- 
Wilcox" test. 
4.4. T,\.T measurenlents (Fig. 2) 
.Aortic blood samples processed as described con- 
tained a substance that was cytostatic for L929 mu- 
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F~g. 2. Time cour,,e of the TNFc, response to LPS rufus]on Or- 
dinate: TNFa levels in units x 103ml - iasdeterminedb~ L929 
bioassa.~ in aortic serum. TNFc, salues in sham-operated group 
(n=3)  remained under the detecuon limit (400 Li ml il. CIo~ed 
circles indicate the sur~ i',ors ( n = 4), open circles indicate the non- 
sur~isor`, (n=5).  Other details as in Fig. I. 
rine fibroblast line. In the survivors, TNF was either 
undetectable or just detectable in the serum until 
30 rain of LPS infusion; at 60 min TNF level was 
clearly increased, but thereafter it declined again. In 
contrast, a marked increase was detected in TNF re- 
lease in non-survivors at the time of death. 
5. Discussion 
Continuous infusion of 5 p.g kg -~ LPS caused 
death in 8 out of 17 pigs treated. Some possibilities 
might be put forward for explaining this split in the 
pig population, such as genetic control on the 
anaount of TNF released follo~.ing continuous LPS 
infusion and."or release of other mediators which 
might down-regulate he release of TNE In this con- 
text, it is claimed that the release of PGE_, might in- 
hibit the release of TNF (quoted in review; ref. 15). 
In view of the fact that no difference was found in 
the plasma concentration of LPS between survivors 
and non-survivors, it seems unlikely that the differ- 
ence in susceptibility to death is due to a difference 
in the clearance of LPS. 
The death caused b} LPS infusion seems to be 
closely related to the amount of TNF release induced 
by LPS. This finding is based on determinations of
cytostasis against he target cell-line L929 (selectixe- 
I$ sensitixe to TNF; refs. 13 and 14) by serum ob- 
tained from LPS-treated pigs. It should be noted 
that the test sera used also contain a certain quantity 
of LPS and, possibly, interleukin 1 (IL-I) released 
either by a direct effect of LPS [16] and/or as a sequel 
toTNF release [16]. It has been mentioned that some 
other factors present in the serum (besides TNF), 
might affect activity against L929 cells [14]. Hox~e~- 
er, circumstantial evidence is strongly in favor of the 
assumption that the cytostatic effect of serum from 
LPS-treated pigs is due to the TNF. This assumption 
is supported by our observations that LPS itself is 
not cytostatic against L929 cells (data not sho~n) 
and by findings of others that L929 cells are not sus- 
ceptible to IL-I [171. Accordingl$; it seems likely that 
death is caused in a certain percentage of LPS- 
infused pigs by a marked increase in TNF release as 
the main mediator for lethality. 
The findings of different susceptibility to the 
lethal effect of LPS in a specified population of pigs 
prox ides an experimental model for determining the 
relation between lethal effect and endotoxic shock. 
In this respect, it is of interest hat pigs survKing 
I_PS infusion remained in a state of shock up to the 
end of the 120-min observation period, i.e., long af- 
ter termination of IPS  infusion and after the blood 
levels of LPS and of released TNF returned to basal 
~alues. The shock state was ascertained by systemic 
hypotension, low cardiac output, hemoconcentra- 
tion, leukocytopenia and hypoglycemia. The results, 
indicating a shock state in surviving pigs long after 
LPS and TNF levels returned to baseline, suggest 
that other mediators besides or instead of TNF are 
responsible for the endotoxic shock observed. The 
release of these mediators (PAF, eicosanoids) might 
be evoked by LPS itself [161 and/or TNE 
In conclusion, we show here a clear distinction be- 
t~een LPS-induced eath and LPS-induced shock. 
This finding implies that different mediators may be 
involved in these two events. 
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